2552 — Hua Medicine Cashflow Statement
0.000.00%
Last trade - 00:00- HK$1.56bn
- HK$160.83m
- CNY76.61m
Annual cashflow statement for Hua Medicine, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -425 | -393 | -326 | -204 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 51.3 | 81.4 | 40.3 | -31.3 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 21.5 | 272 | -19.2 | -27.1 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -342 | -20.9 | -273 | -230 | — |
| Capital Expenditures | -10.3 | -25.7 | -66.9 | -27.5 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.778 | 11.6 | -1.33 | 22.7 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -9.52 | -14.1 | -68.2 | -4.75 | — |
| Financing Cash Flow Items | 0 | — | — | -0.088 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.24 | -7.26 | -6.13 | 21.5 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -338 | -73.5 | -357 | -185 | — |